4//SEC Filing
New Enterprise Associates 16, L.P. 4
Accession 0001209191-23-037333
CIK 0001759425other
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 4:22 PM ET
Size
6.0 KB
Accession
0001209191-23-037333
Insider Transaction Report
Form 4
New Enterprise Associates 16, L.P.
10% Owner
Transactions
- Other
Common Stock
2023-06-13−2,000,000→ 2,186,243 total
Footnotes (2)
- [F1]New Enterprise Associates 16, L.P. ("NEA 16") made a pro rata distribution of 2,000,000 shares of Common Stock of the Issuer to its general partner and limited partners for no consideration on June 13, 2023.
- [F2]The securities are directly held by NEA 16 and are indirectly held by NEA Partners 16, L.P. ("NEA Partners 16"), the sole general partner of NEA 16, NEA 16 GP, LLC ("NEA 16 GP"), the sole general partner of NEA Partners 16, and the individual managers of NEA 16 GP (NEA Partners 16, NEA 16 GP and the individual managers of NEA 16 GP (collectively, the "NEA 16 Managers"), together, the "NEA 16 Indirect Reporting Persons"). The NEA 16 Managers are Forest Baskett, Ali Behbahani, Carmen Chang, Anthony A. Florence, Jr., Mohamad Makhzoumi, Scott D. Sandell and Paul Walker. The NEA 16 Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 16 in which the NEA 16 Indirect Reporting Persons have no pecuniary interest.
Documents
Issuer
Mirum Pharmaceuticals, Inc.
CIK 0001759425
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001694560
Filing Metadata
- Form type
- 4
- Filed
- Jun 14, 8:00 PM ET
- Accepted
- Jun 15, 4:22 PM ET
- Size
- 6.0 KB